Douglas Pharmaceuticals Announces Formation of Clinical Advi

Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107

Related Keywords

Australia , Bristol , City Of , United Kingdom , United States , New Zealand , Sydney , New South Wales , Texas , Cuba , Poland , Baylor College Of Medicine , London , Otago , Stanford , Leicestershire , American , Kennetht Norris Jr , Alanf Schatzberg , Peter Surman , Sanjayj Mathew , Allan Young , American Psychiatric Association , Trial Steering Committee , Stanford Mood Disorders Center , Young , National Academy Of Medicine , Head Of The Department Psychiatry , Behavioural Sciences , University Of Otago , National Affective Disorders Tertiary Clinic , Dog Institute , Department At Stanford , Care Clinical Academic Group , Head Of School , Centre For Affective Disorders , Department Of Psychological Medicine , International Society , University Of Gdansk , Prnewswire Douglas Pharmaceuticals , National Institute For Health Research , University Of New South Wales , Editor For Journal Of Psychiatric Research , Mental Health Biomedical Research Centre , Institute Of Psychiatry , European College Of Neuropsychopharmacology , New Zealand Pharmaceutical , Chief Scientific , Paul Glue , Hazel Buckland Professor , Board Chair , Stanford University , Emeritus Editor , National Academy , Vice Chair , Anxiety Disorders Program , Baylor College , Mood Disorders , Affective Disorders , Psychological Medicine , Academic Psychiatry , College London , National Institute , Health Research , Translational Therapeutics , Integrated Care Clinical Academic Group , South London , Consultant Psychiatrist , National Affective Disorders Tertiary , Thomson Reuters Highly Cited Researchers , Medical University , European Neuropsychopharmacology , European College , Rapid Acting Antidepressants , Colleen Loo , Interventional Psychiatry , Black Dog Institute , Transcranial Magnetic Stimulation , Direct Current Stimulation ,